RA
AMRI

Raffles Associates’s Albany Molecular Research Inc AMRI Stock Holding History

Raffles Associates’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-25,000
Closed -$552K – 66
2014
Q3 		$552K Hold
25,000
– – 0.49% 49
2014
Q2 		$503K Hold
25,000
– – 0.4% 48
2014
Q1 		$465K Hold
25,000
– – 0.46% 44
2013
Q4 		$252K Buy
+25,000
New +$302K 0.26% 45

Other funds holding AMRI

VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PIP
Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
ACM
American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return

Raffles Associates's AMRI Position: Q4 2014 in Review

Raffles Associates sold out of Albany Molecular Research Inc (AMRI) in Q4 2014, closing a stake of 25,000 shares — an estimated $552K sold.

Raffles Associates first reported a position in AMRI in Q4 2013 and held it in 4 quarters. The position peaked at $552K in Q3 2014. 132 funds tracked by Wall St. Rank hold AMRI as of Q4 2014.

  • Raffles Associates reported no remaining Albany Molecular Research Inc position as of Q4 2014 after selling out during the quarter.
  • Raffles Associates sold 25,000 Albany Molecular Research Inc shares in Q4 2014, an estimated $552K.
  • Raffles Associates first reported a position in Albany Molecular Research Inc in Q4 2013 and held it in 4 quarters.
  • Raffles Associates's Albany Molecular Research Inc position peaked at $552K in Q3 2014.
  • 132 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q4 2014.

Based on Raffles Associates's 13F filing for Q4 2014, filed 13 Feb 2015.